| |
 |
|
Class Information
Number: 514/381
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > Tetrazoles (including hydrogenated)
Description: Subject matter wherein the five-membered hetero ring consists of four ring nitrogens and one ring carbon and may have double bond between ring members.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6995182 |
1-sulfonyl pyrrolidine derivatives |
Feb. 7, 2006 |
| 6987112 |
Organic compound having cyano group and insecticides/miticides |
Jan. 17, 2006 |
| 6984651 |
Piperidine amides as modulators of chemokine receptor activity |
Jan. 10, 2006 |
| 6984633 |
Method to treat cardiofibrosis with a combination therapy of an angiotensin II antagonist and epoxymexrenone |
Jan. 10, 2006 |
| 6982264 |
Substituted alcohols useful in treatment of Alzheimer's disease |
Jan. 3, 2006 |
| 6967196 |
Sulfonamide compounds and uses thereof |
Nov. 22, 2005 |
| 6962936 |
Triazole-derived kinase inhibitors and uses thereof |
Nov. 8, 2005 |
| 6951878 |
Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases) |
Oct. 4, 2005 |
| 6951874 |
Compounds |
Oct. 4, 2005 |
| 6949575 |
Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
Sep. 27, 2005 |
| 6949546 |
N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity |
Sep. 27, 2005 |
| 6946492 |
Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity |
Sep. 20, 2005 |
| 6946474 |
Nitrogen-containing compounds and their use as glycine transport inhibitors |
Sep. 20, 2005 |
| 6939886 |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
Sep. 6, 2005 |
| 6936596 |
Adenosine derivatives and use thereof |
Aug. 30, 2005 |
| 6927217 |
HIV protease inhibitors |
Aug. 9, 2005 |
| 6919343 |
N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
Jul. 19, 2005 |
| 6919368 |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
Jul. 19, 2005 |
| 6916821 |
Methods of treating disorders with Group I mGluR antagonists |
Jul. 12, 2005 |
| 6911463 |
3-substituted oxindole .beta.-3 agonists |
Jun. 28, 2005 |
| 6911461 |
2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
Jun. 28, 2005 |
| 6903086 |
Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists |
Jun. 7, 2005 |
| 6900234 |
Synergistic therapeutic compositions and methods |
May. 31, 2005 |
| 6900207 |
N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient |
May. 31, 2005 |
| 6897234 |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
May. 24, 2005 |
| 6890931 |
Methods of treating disorders with group I mGluR antagonists |
May. 10, 2005 |
| 6881727 |
Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
Apr. 19, 2005 |
| 6878703 |
Pharmaceutical composition |
Apr. 12, 2005 |
| 6875776 |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
Apr. 5, 2005 |
| 6875786 |
Thrombopoietin mimetics |
Apr. 5, 2005 |
| 6869970 |
Crystalline salt forms of valsartan |
Mar. 22, 2005 |
| 6864276 |
Active substance combinations having insecticidal and acaricidal properties |
Mar. 8, 2005 |
| 6858636 |
1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
Feb. 22, 2005 |
| 6858634 |
Controlled release formulations and methods for their production and use |
Feb. 22, 2005 |
| 6852743 |
Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof |
Feb. 8, 2005 |
| 6852746 |
Crystalline drug form |
Feb. 8, 2005 |
| 6852747 |
Resorcinol derivatives |
Feb. 8, 2005 |
| 6849618 |
Uracil substituted phenyl sulfamoly carboxamides |
Feb. 1, 2005 |
| 6849626 |
Aza-amino acid derivatives (factor Xa inhibitors 15) |
Feb. 1, 2005 |
| 6846839 |
Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis |
Jan. 25, 2005 |
| 6841563 |
Aryloxy propanolamines for improving livestock production |
Jan. 11, 2005 |
| 6821960 |
Glucagon antagonists/inverse agonists |
Nov. 23, 2004 |
| 6812240 |
8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
Nov. 2, 2004 |
| 6812237 |
N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
Nov. 2, 2004 |
| 6800654 |
Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
Oct. 5, 2004 |
| 6797504 |
Inhibitors of serine protease activity of matriptase or MTSP1 |
Sep. 28, 2004 |
| 6797708 |
Inhibitors of cytosolic phospholipase A2 |
Sep. 28, 2004 |
| 6794404 |
Viral polymerase inhibitors |
Sep. 21, 2004 |
| 6794406 |
Indole derivatives |
Sep. 21, 2004 |
| 6787556 |
Benzoic acid derivatives for the treatment of diabetes mellitus |
Sep. 7, 2004 |
|
|
|
